STAGE IVA LARYNGEAL CANCER AJCC V8
Clinical trials for STAGE IVA LARYNGEAL CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IVA LARYNGEAL CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IVA LARYNGEAL CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising combo aims to shrink tough head and neck cancers
Disease control OngoingThis study tests whether adding an immunotherapy drug (cemiplimab) to low-dose chemotherapy can shrink tumors in people with head and neck cancer that has returned or spread. About 46 adults who have not had prior treatment for advanced disease will receive the combination. The m…
Matched conditions: STAGE IVA LARYNGEAL CANCER AJCC V8
Phase: PHASE2 • Sponsor: Marcelo Bonomi • Aim: Disease control
Last updated May 17, 2026 06:31 UTC
-
New drug combo offers hope for head and neck cancer patients who Can't take standard chemo
Disease control OngoingThis early-stage trial tests a drug called peposertib combined with radiation therapy for people with advanced head and neck cancer who cannot take the standard chemotherapy drug cisplatin. The goal is to find the safest dose of peposertib and see if the combination helps control…
Matched conditions: STAGE IVA LARYNGEAL CANCER AJCC V8
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 06:16 UTC